George Soros’ Soros Fund Management disclosed in an SEC filing its holdings as of March 31, 2024. The fund’s new buys during the first quarter included, by size of position, Cerevel Therapeutics (CERE), Okta (OKTA), WestRock (WRK), PG&E (PCG), and Sunrun (RUN). Soros exited five holdings during the quarter, including by size of previous position iShares Russell 2000 ETF (IWM), SPDR S&P 500 ETF Trust (SPY), SPDR Euro Stoxx 50 ETF (FEZ), Las Vegas Sands (LVS), and Birkenstock (BIRK). The fund increased its stake in multiple holdings, including by size of previous position Alphabet Class A (GOOGL), Aramark (ARMK), D.R. Horton (DHI), American Equity (AEL), and SPDR S&P Regional Banking ETF (KRE). Soros reduced its stake in multiple holdings, including by size of previous position Novo (NVO), Sempra (SRE), CRH (CRH), Amazon (AMZN), and AerCap (AER). The fund’s top holdings as of March 31, in order of size, were Alphabet Class A, AerCap, American Equity, Novo, and Cerevel.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CERE:
- CERE Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Cerevel Therapeutics’ tavapadon meets Phase 3 primary endpoint in Parkinson’s
- Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial for People Living with Parkinson’s Disease
- CERE Upcoming Earnings Report: What to Expect?